NCI Workshop Report: Clinical and Computational Requirements for Correlating Imaging Phenotypes with Genomics Signatures
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The National Cancer Institute (NCI) Cancer Imaging Program organized two related workshops on June 26-27, 2013, entitled "Correlating Imaging Phenotypes with Genomics Signatures Research" and "Scalable Computational Resources as Required for Imaging-Genomics Decision Support Systems." The first workshop focused on clinical and scientific requirements, exploring our knowledge of phenotypic characteristics of cancer biological properties to determine whether the field is sufficiently advanced to correlate with imaging phenotypes that underpin genomics and clinical outcomes, and exploring new scientific methods to extract phenotypic features from medical images and relate them to genomics analyses. The second workshop focused on computational methods that explore informatics and computational requirements to extract phenotypic features from medical images and relate them to genomics analyses and improve the accessibility and speed of dissemination of existing NIH resources. These workshops linked clinical and scientific requirements of currently known phenotypic and genotypic cancer biology characteristics with imaging phenotypes that underpin genomics and clinical outcomes. The group generated a set of recommendations to NCI leadership and the research community that encourage and support development of the emerging radiogenomics research field to address short-and longer-term goals in cancer research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
Aerts, H. J. W. L., Velazquez, E. R., Leijenaar, R. T. H., Parmar, C., Grossmann, P., Carvalho, S., Bussink, J., Monshouwer, R., Haibe-Kains, B., Rietveld, D., et al. (2014) · Nature Communications · doi:10.1038/ncomms5006 · Cited by 5,132 · cited 1×
“Mathematical approaches for dimension reduction and the validation of these approaches using clinical data are urgently needed in order to integrate these disparate datasets [2 – 4].”
MethodSelf-citationThe clonal and mutational evolution spectrum of primary triple-negative breast cancers
Shah, S. P., Roth, A., Goya, R., Oloumi, A., Ha, G., Zhao, Y., Turashvili, G., Ding, J., Tse, K., Haffari, G., et al. (2012) · Nature · doi:10.1038/nature10933 · Cited by 1,967 · cited 1×
“Recent massively parallel sequencing studies and epigenetic analysis of different tumor types have revealed that cancers are composed of mosaics of non-modal clones [30,31] which harbor distinct constellations of genomic alterations in addition to the founder genetic events, and that clonal selection occurs during met…”
BackgroundThe molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
Diaz Jr, L. A., Williams, R. T., Wu, J., Kinde, I., Hecht, J. R., Berlin, J., Allen, B., Bozic, I., Reiter, J. G., Nowak, M. A., et al. (2012) · Nature · doi:10.1038/nature11219 · Cited by 1,713 · cited 2×
“Several cancer-related pathways were differentially enriched among the morphology clusters, including the ATM and TP53 DNA damage checkpoints, the NF-κ B pathway, and the Wnt signaling and PTEN-AKT pathways.”
BackgroundIntratumor Heterogeneity: Evolution through Space and Time
Swanton, C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2217 · Cited by 931
Decoding global gene expression programs in liver cancer by noninvasive imaging
Segal, E., Sirlin, C. B., Ooi, C., Adler, A. S., Gollub, J., Chen, X., Chan, B. K., Matcuk, G. R., Barry, C. T., Chang, H. Y., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1306 · Cited by 629 · cited 1×
“This inability to distinguish different cell/tissue types with tracer signals can confound compartment modeling and deep phenotyping for association studies [37 – 39].”
BackgroundAnimal models of human disease: challenges in enabling translation
McGonigle, P., & Ruggeri, B. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.08.006 · Cited by 610 · cited 1×
“, patientderived xenografts, transgenic) are routinely used for drug efficacy and toxicity testing [49,50].”
MethodQuantitative Imaging in Cancer Evolution and Ecology
Gatenby, R. A., Grove, O., & Gillies, R. J. (2013) · Radiology · doi:10.1148/radiol.13122697 · Cited by 515
Self-citationA murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response
Chen, Z., Cheng, K., Walton, Z., Wang, Y., Ebi, H., Shimamura, T., Liu, Y., Tupper, T., Ouyang, J., Li, J., et al. (2012) · Nature · doi:10.1038/nature10937 · Cited by 446 · cited 2×
“This newer approach to integrated cross-species testing, termed coclinical trials, involves concurrent assessment of novel drug combinations in mouse and human-in-mouse models of tumors, and in patients with recurrent or metastatic disease with whom the mice are genotypically matched [52,53].”
BackgroundQuantitative Image Analysis of Cellular Heterogeneity in Breast Tumors Complements Genomic Profiling
Yuan, Y., Failmezger, H., Rueda, O. M., Ali, H. R., Gräf, S., Chin, S.-F., Schwarz, R. F., Curtis, C., Dunning, M. J., Bardwell, H., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004330 · Cited by 426
Giger, M. L., Chan, H., & Boone, J. (2008) · Medical Physics · doi:10.1118/1.3013555 · Cited by 311 · cited 1×
“have been developing and investigating computerized quantitative methods for extracting data from multi‐ modality breast images and mining the data to yield image‐based phenotypes relating to breast cancer risk, diagnosis, prognosis, and response to therapy [18–20].”
MethodSelf-citation
Cited by
Radiomics: the bridge between medical imaging and personalized medicine
Lambin, P., Leijenaar, R. T. H., Deist, T. M., Peerlings, J., de Jong, E. E. C., van Timmeren, J., Sanduleanu, S., Larue, R. T. H. M., Even, A. J. G., Jochems, A., et al. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.141 · Cited by 5,688
Reproducibility of radiomics for deciphering tumor phenotype with imaging
Zhao, B., Tan, Y., Tsai, W.-Y., Qi, J., Xie, C., Lu, L., & Schwartz, L. H. (2016) · Scientific Reports · doi:10.1038/srep23428 · Cited by 509
Sala, E., Mema, E., Himoto, Y., Veeraraghavan, H., Brenton, J. D., Snyder, A., Weigelt, B., & Vargas, H. A. (2017) · Clinical Radiology · doi:10.1016/j.crad.2016.09.013 · Cited by 369
Li, H., Zhu, Y., Burnside, E. S., Huang, E., Drukker, K., Hoadley, K. A., Fan, C., Conzen, S. D., Zuley, M., Net, J. M., et al. (2016) · npj Breast Cancer · doi:10.1038/npjbcancer.2016.12 · Cited by 364
Self-citationRadiogenomics: bridging imaging and genomics
Bodalal, Z., Trebeschi, S., Nguyen-Kim, T. D. L., Schats, W., & Beets-Tan, R. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-02028-w · Cited by 310
“[213] TP53, RB1, NF1, EGFR, and PDGFRA Correlative Volumetric – Contrast enhancement, necrosis, edema volumes MRI”
BackgroundCT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer
Rizzo, S., Petrella, F., Buscarino, V., De Maria, F., Raimondi, S., Barberis, M., Fumagalli, C., Spitaleri, G., Rampinelli, C., De Marinis, F., et al. (2016) · European Radiology · doi:10.1007/s00330-015-3814-0 · Cited by 270
Saltz, J., Sharma, A., Iyer, G., Bremer, E., Wang, F., Jasniewski, A., DiPrima, T., Almeida, J. S., Gao, Y., Zhao, T., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0316 · Cited by 60
Self-citation
Metadata
- Authors
- Colen, R., Foster, I., Gatenby, R., Giger, M. E., Gillies, R., Gutman, D., Heller, M., Jain, R., Madabhushi, A., Madhavan, S., Napel, S., Rao, A., Saltz, J., Tatum, J., Verhaak, R., & Whitman, G.
- Venue
- Translational Oncology
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 7
- Issue
- 5
- Pages
- 556-569
- ISSN
- 1936-5233 (ISSN-L)
- OpenAlex
- W2172058373
- Cited by
- 72
- References
- 10
- FWCI
- 7.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.